Vaishnavi Chemicals Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 11-12-2024
- Paid Up Capital ₹ 0.10 M
as on 11-12-2024
- Company Age 21 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.72 Cr
as on 11-12-2024
- Satisfied Charges ₹ 6.00 M
as on 11-12-2024
- Revenue 13.93%
(FY 2022)
- Profit -14.32%
(FY 2022)
- Ebitda 2541.22%
(FY 2022)
- Net Worth 53.84%
(FY 2022)
- Total Assets 15.45%
(FY 2022)
About Vaishnavi Chemicals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.72 Cr. The company has closed loans amounting to ₹6.00 M, as per Ministry of Corporate Affairs (MCA) records.
Anjali Satoskar and Anita Satoskar serve as directors at the Company.
- CIN/LLPIN
U24244MH2003PTC139272
- Company No.
139272
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Feb 2003
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Vaishnavi Chemicals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anjali Satoskar  | Director | 20-Feb-2003 | Current |
| Anita Satoskar | Director | 20-Feb-2003 | Current |
Financial Performance of Vaishnavi Chemicals.
Vaishnavi Chemicals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 13.93% increase. The company also saw a substantial fall in profitability, with a 14.32% decrease in profit. The company's net worth Soared by an impressive increase of 53.84%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vaishnavi Chemicals?
Unlock access to Vaishnavi Chemicals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
The Saraswat Co-Operative Bank Ltd. Creation Date: 15 Feb 2014 | ₹4.00 M | Open |
The Saraswat Co-Operative Bank Limited Creation Date: 19 Mar 2013 | ₹2.50 M | Open |
The Saraswat Co.Op. Bank Limited Creation Date: 03 Jun 2010 | ₹6.33 M | Open |
How Many Employees Work at Vaishnavi Chemicals?
Unlock and access historical data on people associated with Vaishnavi Chemicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vaishnavi Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vaishnavi Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
